KELSIE FUBIO: Open Payments
NPI 1922843440 · MORGANTOWN, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$285 in 16 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $93 · 2025 $285
Food & beverage: $285
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $67 |
| GlaxoSmithKline, LLC. | 3 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Phathom Pharmaceuticals, Inc. | 2 | $43 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $28 |
| Novo Nordisk Inc | 1 | $17 |
Products named: AIRSUPRA, TRELEGY ELLIPTA, Kerendia, VOQUEZNA, XIFAXAN, JARDIANCE, Wegovy, BREZTRI.
Industry payments across WV — which companies pay providers there.
